Abstract

Background: We provided a comparative presentation of complications seen in 114 patients with port catheter implantation. In addition, we addressed whether patients with catheter-related thrombosis have distinctive features by assessing patients who developed thrombosis either at the catheter implant site or vascular bed.
 Methods: In this study, we analyzed data from 114 patients who underwent subclavian venous port catheter implantation by a single surgeon at Kayseri Teaching Hospital (Turkey) during 2013 to 2016. Subclavian port catheter was inserted in all cases. The diagnosis of port thrombosis was made by Doppler sonography or thorax CT scan with contrast enhancement in patients presenting with edema at upper extremity, swelling or pain at neck, and/or dysfunctional port.
 Results: Seroma was detected in only one case, lymphedema developed in one case (0.8%), and pneumothorax was observed in 3 cases. The subclavian vein was implanted on the right side in all patients with pneumothorax. None of these cases were associated with thrombosis. Port infection was observed in one case (0.8%). There was also one case (0.8%) of skin necrosis. The port was removed in 15 patients due to several reasons, which are indicated in Table 2. Thromboembolic events were observed in 11 of the 114 patients while port thrombosis was observed in 7 patients. The rate of hypertension in the thromboembolism group was 61.1% (11/18 individual) while the rate of hypertension in the group without thromboembolism was 28.1% (27/96 individuals); this difference was statistically significant (p = 0.006).
 Conclusion: In this study, based on complications observed in patients with catheter-related thrombosis, factors such as smoking or diabetes mellitus were seen to be linked to thromboembolism and should be taken into consideration. Moreover, it was observed that hypertension had a significant association with thromboembolism.

Highlights

  • Venous ports were first introduced by Niederberhuber et al in 1982 (Niederhuber et al, 1982)

  • In this study, based on complications observed in patients with catheter-related thrombosis, factors such as smoking or diabetes mellitus were seen to be linked to thromboembolism and should be taken into consideration

  • It was observed that hypertension had a significant association with thromboembolism

Read more

Summary

Introduction

Venous ports were first introduced by Niederberhuber et al in 1982 (Niederhuber et al, 1982). Venous port systems are used to administer chemotherapy in oncology. They may be used for volume replacement, detoxification, blood and blood product transfusion, intravenous infusion of sclerosing agents, other drug infusions, parenteral nutrition, laboratory follow-up, and diagnostic purposes (Biffi et al, 2009; Esfahani et al, 2016; Ignatov et al, 2009). The catheters prevent trauma and contribute to comfort in patients requiring periodical blood sampling They have other advantages such as enabling sclerosing agent infusion and facilitating fluid replacement. Subclavian port catheter was inserted in all cases. The subclavian vein was implanted on the right side in all patients with pneumothorax None of these cases were associated with thrombosis.

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call